{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:34:26Z","timestamp":1792424066605,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00277-025-06395-x","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T01:18:34Z","timestamp":1746407914000},"page":"2799-2811","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes of the transformation to diffuse large B-cell lymphoma in hodgkin lymphoma and indolent B-cell non-Hodgkin lymphoma: a population-based study"],"prefix":"10.1007","volume":"104","author":[{"given":"Wenshuai","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"issue":"4","key":"6395_CR1","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1200\/JCO.1997.15.4.1587","volume":"15","author":"Y Bastion","year":"1997","unstructured":"Bastion Y, Sebban C, Berger F et al (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. J Clin Oncol 15(4):1587\u20131594","journal-title":"J Clin Oncol"},{"issue":"2","key":"6395_CR2","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1053\/j.seminoncol.2006.01.016","volume":"33","author":"AM Tsimberidou","year":"2006","unstructured":"Tsimberidou AM, Keating MJ (2006) Richter\u2019s transformation in chronic lymphocytic leukemia. Semin Oncol 33(2):250\u2013256","journal-title":"Semin Oncol"},{"issue":"3","key":"6395_CR3","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/cncr.24819","volume":"116","author":"I Biasoli","year":"2010","unstructured":"Biasoli I, Stamatoullas A, Meignin V et al (2010) Nodular, lymphocyte-predominant hodgkin lymphoma: a long-term study and analysis of transformation to diffuse large B-cell lymphoma in a cohort of 164 patients from the adult lymphoma study group. Cancer 116(3):631\u2013639","journal-title":"Cancer"},{"issue":"7","key":"6395_CR4","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1182\/blood-2015-01-621375","volume":"126","author":"ND Wagner-Johnston","year":"2015","unstructured":"Wagner-Johnston ND, Link BK, Byrtek M et al (2015) Outcomes of transformed follicular lymphoma in the modern era: a report from the National lymphocare study (NLCS). Blood 126(7):851\u2013857","journal-title":"Blood"},{"issue":"4","key":"6395_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/bjh.12570","volume":"163","author":"M Ban-Hoefen","year":"2013","unstructured":"Ban-Hoefen M, Vanderplas A, Crosby-Thompson AL et al (2013) Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database. Br J Haematol 163(4):487\u2013495","journal-title":"Br J Haematol"},{"issue":"6","key":"6395_CR6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/bjh.14153","volume":"174","author":"AM Maeshima","year":"2016","unstructured":"Maeshima AM, Taniguchi H, Toyoda K et al (2016) Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa\u2010associated lymphoid tissue to diffuse large B\u2010cell lymphoma: an analysis of 467 patients. Br J Haematol 174(6):923\u2013931","journal-title":"Br J Haematol"},{"issue":"8","key":"6395_CR7","doi-asserted-by":"publisher","first-page":"e7120","DOI":"10.1002\/cam4.7120","volume":"13","author":"W Zheng","year":"2024","unstructured":"Zheng W, Liu M, Guan L, Wang S (2024) Outcomes of the transformation of follicular lymphoma to diffuse large B-cell lymphoma in the rituximab era: A population-based study. Cancer Med 13(8):e7120","journal-title":"Cancer Med"},{"key":"6395_CR8","doi-asserted-by":"crossref","unstructured":"Kalashnikov I, Tanskanen T, Pitk\u00e4niemi J, Malila N, Jyrkki\u00f6 S, Lepp\u00e4 S (2021) Transformation and outcome of nodular lymphocyte predominant hodgkin lymphoma: a Finnish nationwide population-based study. Blood Cancer J 11(12)","DOI":"10.1038\/s41408-021-00586-1"},{"issue":"16","key":"6395_CR9","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1182\/blood-2015-08-665505","volume":"127","author":"SS Kenderian","year":"2016","unstructured":"Kenderian SS, Habermann TM, Macon WR et al (2016) Large B-cell transformation in nodular lymphocyte-predominant hodgkin lymphoma: 40-year experience from a single institution. Blood 127(16):1960\u20131966","journal-title":"Blood"},{"issue":"Suppl 24","key":"6395_CR10","doi-asserted-by":"publisher","first-page":"4969","DOI":"10.1002\/cncr.30905","volume":"123","author":"MC White","year":"2017","unstructured":"White MC, Babcock F, Hayes NS et al (2017) The history and use of cancer registry data by public health cancer control programs in the united States. Cancer 123(Suppl 24):4969\u20134976","journal-title":"Cancer"},{"issue":"1","key":"6395_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/jebm.12373","volume":"13","author":"J Yang","year":"2020","unstructured":"Yang J, Li Y, Liu Q et al (2020) Brief introduction of medical database and data mining technology in big data era. J evidence-based Med 13(1):57\u201369","journal-title":"J evidence-based Med"},{"issue":"1","key":"6395_CR12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s40779-021-00338-z","volume":"8","author":"WT Wu","year":"2021","unstructured":"Wu WT, Li YJ, Feng AZ et al (2021) Data mining in clinical big data: the frequently used databases, steps, and methodological models. Military Med Res 8(1):44","journal-title":"Military Med Res"},{"issue":"3","key":"6395_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC (2011) An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res 46(3):399\u2013424","journal-title":"Multivar Behav Res"},{"issue":"1","key":"6395_CR14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/annonc\/mdt507","volume":"25","author":"AH Meyer","year":"2014","unstructured":"Meyer AH, Stroux A, Lerch K et al (2014) Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma. Ann Oncol 25(1):210\u2013215","journal-title":"Ann Oncol"},{"issue":"10","key":"6395_CR15","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1002\/ajh.24477","volume":"91","author":"JJ Castillo","year":"2016","unstructured":"Castillo JJ, Gustine J, Meid K, Dubeau T, Hunter ZR, Treon SP (2016) Histological transformation to diffuse large B-cell lymphoma in patients with Waldenstr\u00f6m macroglobulinemia. Am J Hematol 91(10):1032\u20131035","journal-title":"Am J Hematol"},{"issue":"6","key":"6395_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/bjh.12458","volume":"162","author":"SA Parikh","year":"2013","unstructured":"Parikh SA, Rabe KG, Call TG et al (2013) Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients. Br J Haematol 162(6):774\u2013782","journal-title":"Br J Haematol"},{"issue":"10","key":"6395_CR17","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1007\/s00277-021-04603-y","volume":"100","author":"R Elnair","year":"2021","unstructured":"Elnair R, Ellithi M, Kallam A, Shostrom V, Bociek RG (2021) Outcomes of Richter\u2019s transformation of chronic lymphocytic leukemia\/small lymphocytic lymphoma (CLL\/SLL): an analysis of the SEER database. Ann Hematol 100(10):2513\u20132519","journal-title":"Ann Hematol"},{"issue":"2","key":"6395_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s13524-011-0032-5","volume":"48","author":"MS Rendall","year":"2011","unstructured":"Rendall MS, Weden MM, Favreault MM, Waldron H (2011) The protective effect of marriage for survival: a review and update. Demography 48(2):481\u2013506","journal-title":"Demography"},{"issue":"3","key":"6395_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1200\/JCO.2001.19.3.727","volume":"19","author":"CD Williams","year":"2001","unstructured":"Williams CD, Harrison CN, Lister TA et al (2001) High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin\u2019s lymphoma: a case-matched study from the European bone marrow transplant registry. J Clin Oncol 19(3):727\u2013735","journal-title":"J Clin Oncol"},{"issue":"4","key":"6395_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1053\/bbmt.1999.v5.pm10465106","volume":"5","author":"JW Friedberg","year":"1999","unstructured":"Friedberg JW, Neuberg D, Gribben JG et al (1999) Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies. Biol Blood Marrow Transpl 5(4):262\u2013268","journal-title":"Biol Blood Marrow Transpl"},{"issue":"5","key":"6395_CR21","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2141.2010.08519.x","volume":"152","author":"MB Eide","year":"2011","unstructured":"Eide MB, Lauritzsen GF, Kvalheim G et al (2011) High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. Br J Haematol 152(5):600\u2013610","journal-title":"Br J Haematol"},{"issue":"22","key":"6395_CR22","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1200\/JCO.2015.65.7163","volume":"34","author":"C Sarkozy","year":"2016","unstructured":"Sarkozy C, Trneny M, Xerri L et al (2016) Risk factors and outcomes for patients with follicular lymphoma who had histologic transformation after response to First-Line immunochemotherapy in the PRIMA trial. J Clin Oncol 34(22):2575\u20132582","journal-title":"J Clin Oncol"},{"issue":"5","key":"6395_CR23","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1111\/bjh.14831","volume":"178","author":"S Alonso-\u00c1lvarez","year":"2017","unstructured":"Alonso-\u00c1lvarez S, Magnano L, Alcoceba M et al (2017) Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group. Br J Haematol 178(5):699\u2013708","journal-title":"Br J Haematol"},{"issue":"26","key":"6395_CR24","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1200\/JCO.2012.48.3990","volume":"31","author":"BK Link","year":"2013","unstructured":"Link BK, Maurer MJ, Nowakowski GS et al (2013) Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: a report from the university of Iowa\/MayoClinic specialized program of research excellence molecular epidemiology resource. J Clin Oncol 31(26):3272\u20133278","journal-title":"J Clin Oncol"},{"issue":"6","key":"6395_CR25","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00277-015-2303-5","volume":"94","author":"K Lerch","year":"2015","unstructured":"Lerch K, Meyer AH, Stroux A et al (2015) Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de Novo diffuse large B cell lymphoma: a retrospective multicentre analysis. Ann Hematol 94(6):981\u2013988","journal-title":"Ann Hematol"},{"issue":"2","key":"6395_CR26","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/annonc\/mdu537","volume":"26","author":"C Madsen","year":"2015","unstructured":"Madsen C, Pedersen MB, Vase M\u00d8 et al (2015) Outcome determinants for transformed indolent lymphomas treated with or without autologous stem-cell transplantation. Ann Oncol 26(2):393\u2013399","journal-title":"Ann Oncol"},{"key":"6395_CR27","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1182\/asheducation-2015.1.625","volume":"2015","author":"S Montoto","year":"2015","unstructured":"Montoto S (2015) Treatment of patients with transformed lymphoma. Hematol Am Soc Hematol Educ Program 2015:625\u2013630","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"12","key":"6395_CR28","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.bbmt.2016.09.013","volume":"22","author":"MA Kharfan-Dabaja","year":"2016","unstructured":"Kharfan-Dabaja MA, Kumar A, Hamadani M et al (2016) Clinical practice recommendations for use of allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia on behalf of the guidelines committee of the American society for blood and marrow transplantation. Biol Blood Marrow Transpl 22(12):2117\u20132125","journal-title":"Biol Blood Marrow Transpl"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06395-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06395-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06395-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T06:37:41Z","timestamp":1749105461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06395-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["6395"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06395-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}